Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
rituximab (rituxan) (1 trial)
Myoclonus (Phase 2)
Ocular Motility Disorders (Phase 2)
Opsoclonus-Myoclonus Syndrome (Phase 2)
Syndrome (Phase 2)
Trials (1 total)
Trial APIs (1 total)